Gilla Kaplan is a director of Avalo Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Tyra Biosciences, Inc.
18 Jun 24
4
Tyra Biosciences, Inc.
31 May 24
4
Avalo Therapeutics, Inc.
21 Dec 23
4
Tyra Biosciences, Inc.
2 Jun 23
4
Avalo Therapeutics, Inc.
3 Oct 22
4
Avalo Therapeutics, Inc.
1 Jul 22
4
Tyra Biosciences, Inc.
15 Jun 22
4
Avalo Therapeutics, Inc.
15 Jun 22
4
Avalo Therapeutics, Inc.
4 Apr 22
4
Avalo Therapeutics, Inc.
4 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 24 | TYRA Tyra Biosciences | Common Stock | Option exercise | Acquire M | No | No | 0.61 | 61,392 | 37.45 k | 89,623 |
13 Jun 24 | TYRA Tyra Biosciences | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.61 | 61,392 | 37.45 k | 0 |
29 May 24 | TYRA Tyra Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 15.94 | 18,600 | 296.48 k | 18,600 |
20 Dec 23 | AVTX Avalo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.043 | 3,334 | 143.36 | 3,334 |
31 May 23 | TYRA Tyra Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 14.47 | 14,500 | 209.82 k | 14,500 |